Pharmacologically targeting of the GPCRs, relaxin family peptide receptors (RXFPs) (#14)
M. Akhter Hossain
1
,
Martina Kocan
2
,
Vinojini Nair
3
,
John Karas
3
,
Nitin Patil
3
,
Keiko Hojo
4
,
Johan Rosengren
5
,
Richard Hughes
6
,
Johannes Grosse
7
,
Roger Summers
6
,
Chrishan Samuel
8
,
Ross Bathgate
3
,
John Wade
3
- University of Melbourne, Parkville, VIC, Australia
- Monash Institute of Pharmaceutical Science, Parkville, Australia
- Florey Institute of Neuroscience and Mental Health, Parkville, Australia
- Kobe Gakuin University, ,Kobe, Japan
- School of Biomedical Sciences, the University of Queensland, Brisbane, Australia
- Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, Australia
- Takeda Cambridge Ltd., Cambridge, United Kingdom
- Department of Pharmacology, Monash University, Clayton, Australia
Publish consent withheld
- Hossain MA, Wade JD. Curr Opin Chem Biol. 2014, 22:47-55.
- Grosse J, Heffron H, Burling K, Hossain MA, Habib AM, Rogers GJ, Richards P, Larder R, Rimmington D, Adriaenssens AA, Parton L, Powell J, Binda M, Colledge WH, Doran J, Toyoda Y, Wade JD, Aparicio S, Carlton MB, Coll AP, Reimann F, O'Rahilly S, Gribble FM. Proc Natl Acad Sci, U S A. 2014, 111: 11133-8.
- Karas JA, Scanlon DB, Forbes BE, Vetter I, Lewis RJ, Gardiner J, Separovic F, Wade JD, Hossain MA. Chemistry. 2014, 20: 9549-52.
- Belgi A, Bathgate RA, Kocan M, Patil N, Zhang S, Tregear GW, Wade JD, Hossain MA. J Med Chem. 2013, 56: 9509-16.